RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • A phase I open-label clinical trial to study drug-drug interactions of Dorzagliatin and Sitagliptin in patients with type 2 diabetes and obesity

A phase I open-label clinical trial to study drug-drug interactions of Dorzagliatin and Sitagliptin in patients with type 2 diabetes and obesity

Add to Collection
RCTs L Chen, J Zhang, Y Sun, Y Zhao, X Liu, Z Fang… - Nature …, 2023 - nature.com

Chapter : Section9
Journal Year : 2023
Cited by : 2

… As a new class of diabetes medicine, dorzagliatin was considered safe and effective in T2D … glycemic control rate in both trials with minimum hypoglycemia 15,16 . A logistic regression …..... Read More

Keywords : ['study drugdrug interaction', 'openlabel clinical trial', 'type diabetes', 'sitagliptin', 'phase', 'patient', 'obesity', 'dorzagliatin']
PubMed Link : https://www.nature.com/articles/s41467-023-36946-7
Google Scholar Link : https://scholar.google.com/scholar?cites=10012610055426459025&as_sdt=2005&sciodt=0,5&hl=en&num=20